https://finance.yahoo.com/news/nektar-bristol-myers-end-clinical-204205857.html
https://finance.yahoo.com/m/8ae64bd8-069b-3bda-92e7-d571b0a72cc4/nektar-therapeutics-stock.html
https://aacrjournals.org/cancerdiscovery/article/10/8/1158/2710/Bempegaldesleukin-NKTR-214-plus-Nivolumab-in
https://stockcharts.com/h-sc/ui
That's some background for my previous post about a guy's comments on Nektar. Apparently Bempeg was being trialled with Keytruda and Opdivo individually.
I've got a question for the audience here, and that is "Does anyone remember what checkpoint inhibitor EVT801 was used with in the preclinical trials which showed such synergy?"
- Forums
- ASX - By Stock
- KZA
- KZA Media Thread
KZA Media Thread, page-1935
-
- There are more pages in this discussion • 132 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)